Loco-regional immunotherapy for bladder cancer.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D001500:BCG Vaccine / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D006801:Humans; D007116:Immunization, Passive; D001749:Urinary Bladder Neoplasms / Q000601:surgery / Q000628:therapy*
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine